Mukolitic phytotherapy in respiratory diseases: studies continue
Each year acute bronchitis affects about 5% of the world population. Majority of patients seek medical care when symptoms become severe, especially in the first week of the disease. So far, acute bronchitis is a reason for one million doctor visits per year.
Main Authors: | N. A. Shostak, A. I. Kryukov, N. L. Kunelskaya, A. B. Turovskiy |
---|---|
Format: | Article |
Language: | Russian |
Published: |
Remedium Group LLC
2013-12-01
|
Series: | Медицинский совет |
Subjects: | |
Online Access: | https://www.med-sovet.pro/jour/article/view/1153 |
Similar Items
-
Acute rhinosinusitis: basic misconceptions and the possibilities of standardized phitotherapy
by: A. Y. Ovchinnikov, et al.
Published: (2016-12-01) -
Mucolytic therapy of acute exacerbations of chronic rhinosinusitis
by: N. L. Kunelskaya, et al.
Published: (2015-12-01) -
Acute bronchitis: challenges of diagnosis and treatment
by: I. V. Leschenko
Published: (2013-12-01) -
Effect of ELOM-080 on exacerbations and symptoms in COPD patients with a chronic bronchitis phenotype – a post-hoc analysis of a randomized, double-blind, placebo-controlled clinical trial
by: Beeh KM, et al.
Published: (2016-11-01) -
ASSOCIATION OF CC16 POLYMORPHISM WITH RISK FACTORS OF FORMATION OF BRONCHO-OBSTRUCTIVE SYNDROME IN CHILDREN
by: E N Seliverstova, et al.
Published: (2018-12-01)